United States · FDA National Drug Code directory
Cholestyramine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49884-466_587586f5-0b75-4dc8-b78d-477a66e0cb30
- Product NDC
- 49884-466
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- cholestyramine
- Labeler
- Par Health USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20050915
- Source listing expiry
- 20271231
Source-listed ingredients
- CHOLESTYRAMINE — 4 g/5g
These values do not establish equivalence or a dose recommendation.
Packages
- 210 g in 1 BOTTLE (49884-466-50) · 49884-466-50
- 60 PACKET in 1 CARTON (49884-466-65) / 5 g in 1 PACKET (49884-466-63) · 49884-466-65
- 210 g in 1 CAN (49884-466-67) · 49884-466-67
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →